FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

901811000001108: Co-amilofruse 2.5mg/20mg tablets (Sandoz Ltd) (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
16596501000001110 Co-amilofruse 2.5mg/20mg tablets (Sandoz Ltd) (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
16596601000001114 Co-amilofruse 2.5mg/20mg tablets (Sandoz Ltd) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Co-amilofruse 2.5mg/20mg tablets (Sandoz Ltd) Is a Product containing precisely amiloride hydrochloride 2.5 milligram and furosemide 20 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Co-amilofruse 2.5mg/20mg tablets (Sandoz Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Co-amilofruse 2.5mg/20mg tablets (Sandoz Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Co-amilofruse 2.5mg/20mg tablets (Sandoz Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Co-amilofruse 2.5mg/20mg tablets (Sandoz Ltd) Has active ingredient Furosemide false Inferred relationship Existential restriction modifier
Co-amilofruse 2.5mg/20mg tablets (Sandoz Ltd) Has active ingredient Amiloride hydrochloride false Inferred relationship Existential restriction modifier
Co-amilofruse 2.5mg/20mg tablets (Sandoz Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Co-amilofruse 2.5mg/20mg tablets (Sandoz Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Co-amilofruse 2.5mg/20mg tablets (Sandoz Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Co-amilofruse 2.5mg/20mg tablets (Sandoz Ltd) Has specific active ingredient Furosemide true Inferred relationship Existential restriction modifier
Co-amilofruse 2.5mg/20mg tablets (Sandoz Ltd) Has specific active ingredient Amiloride hydrochloride true Inferred relationship Existential restriction modifier
Co-amilofruse 2.5mg/20mg tablets (Sandoz Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Co-amilofruse 2.5mg/20mg tablets (Sandoz Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Co-amilofruse 2.5mg/20mg tablets (Sandoz Ltd) 28 tablet 2 x 14 tablets Is pack of False Co-amilofruse 2.5mg/20mg tablets (Sandoz Ltd) Inferred relationship Existential restriction modifier
Co-amilofruse 2.5mg/20mg tablets (Sandoz Ltd) 28 tablet 2 x 14 tablets Has AMP True Co-amilofruse 2.5mg/20mg tablets (Sandoz Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start